In breast cancer, miR‐4532 stimulated cell proliferation, anti-apoptosis, disease pathogenesis, disease relapse/metastases and activation of STAT3 and TGFB pathways (Feng et al., 2018; Vora et al., 2024). The gene discussed is TGFB1; the disease is breast carcinoma.